Alexander Jones
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexander Jones has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Samuel Joseph Burden
Department of Women and Children’s Health, School of Life Course and Population Sciences, King’s College London , London
5 shared publications - Helen Dawes
Faculty of Health and Life Science Oxford Brookes University Oxford UK
2 shared publications Luke Whaymand
Centre for Movement, Occupational and Rehabilitation Sciences Oxford Institute of Nursing, Midwifery and Allied Health Research, Oxford Brookes University Oxford UK
2 shared publicationsAjanthiha Karunakaran
Centre for Translational Cardiovascular Imaging University College London London United Kingdom
1 shared publication- Andrew Taylor
Centre for Cardiovascular Imaging, Heart and Lung Division, Great Ormond Street Hospital for Children NHS Foundation Trust
1 shared publication - Anja Hennemuth
Deutsches Herzzentrum der Charite
1 shared publication
Latest Publications
- Open Access
- 23 September 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Microbiome-targeted interventions for early cardiometabolic prevention: a systematic review and meta-analysis in children and adolescents
Aims: Cardiometabolic disease develops across the life course, making childhood critical for cardiovascular prevention. Although microbiome-targeted interventions improve some cardiometabolic outcomes in adults, whether similar interventions influence cardiometabolic risk during childhood remains uncertain. This systematic review and meta-analysis evaluated microbiome-targeted interventions for cardiometabolic outcomes in children and adolescents. Methods and results: A systematic search of PubMed, MEDLINE, Embase, Cochrane CENTRAL, Web of Science, and CINAHL was conducted. Randomized controlled trials assessing dietary interventions, faecal microbiome transfer, prebiotics, probiotics, or synbiotics in participants aged 1 month to 19 years were included. Cardiometabolic outcomes were grouped as adiposity, lipids, liver function, inflammation, glycaemic regulation, and blood pressure. Inverse-variance weighted random-effects meta-analysis with restricted maximum likelihood produced pooled estimates. Sources of heterogeneity (age, sex, and intervention duration) were assessed by meta-regression (PROSPERO CRD42022321814). Twenty-one of 28 included studies were meta-analysed. Compared with placebo, body mass index z-score (Hedges’ g = −0.36, 95% CI −0.64 to −0.08) and C-reactive protein (g = −0.68, −1.27 to −0.09) decreased following microbiome-targeted interventions, with a borderline reduction of alanine aminotransferase (g = −0.33, −0.66 to 0.00); body fat percentage, lipid outcomes, insulin resistance, and blood pressure did not change significantly. In a multivariate analysis across prespecified cardiometabolic markers, a small overall reduction was observed (g = −0.21, −0.33 to −0.10). Conclusion: The pattern of responses to microbiome-targeted interventions was consistent with greater effects on early biological components of paediatric cardiometabolic disease, including adiposity, hepatic dysfunction, and systemic inflammation. Evidence for downstream cardiometabolic risk factor modification was limited. Longer, targeted trials are needed to confirm clinical relevance.
- 23 September 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Open AccessMicrobiome-targeted interventions for early cardiometabolic prevention: a systematic review and meta-analysis in children and adolescents
Aims: Cardiometabolic disease develops across the life course, making childhood critical for cardiovascular prevention. Although microbiome-targeted interventions improve some cardiometabolic outcomes in adults, whether similar interventions influence cardiometabolic risk during childhood remains uncertain. This systematic review and meta-analysis evaluated microbiome-targeted interventions for cardiometabolic outcomes in children and adolescents. Methods and results: A systematic search of PubMed, MEDLINE, Embase, Cochrane CENTRAL, Web of Science, and CINAHL was conducted. Randomized controlled trials assessing dietary interventions, faecal microbiome transfer, prebiotics, probiotics, or synbiotics in participants aged 1 month to 19 years were included. Cardiometabolic outcomes were grouped as adiposity, lipids, liver function, inflammation, glycaemic regulation, and blood pressure. Inverse-variance weighted random-effects meta-analysis with restricted maximum likelihood produced pooled estimates. Sources of heterogeneity (age, sex, and intervention duration) were assessed by meta-regression (PROSPERO CRD42022321814). Twenty-one of 28 included studies were meta-analysed. Compared with placebo, body mass index z-score (Hedges’ g = −0.36, 95% CI −0.64 to −0.08) and C-reactive protein (g = −0.68, −1.27 to −0.09) decreased following microbiome-targeted interventions, with a borderline reduction of alanine aminotransferase (g = −0.33, −0.66 to 0.00); body fat percentage, lipid outcomes, insulin resistance, and blood pressure did not change significantly. In a multivariate analysis across prespecified cardiometabolic markers, a small overall reduction was observed (g = −0.21, −0.33 to −0.10). Conclusion: The pattern of responses to microbiome-targeted interventions was consistent with greater effects on early biological components of paediatric cardiometabolic disease, including adiposity, hepatic dysfunction, and systemic inflammation. Evidence for downstream cardiometabolic risk factor modification was limited. Longer, targeted trials are needed to confirm clinical relevance.
- Open Access
- 18 August 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (16) , e041806
Early Cardiac Dysfunction in Adolescents With Low Vigorous Physical Activity
Background: Adverse left ventricular diastolic function (LVDF) is an early marker of cardiac dysfunction that worsens with age and can lead to heart failure. It is unclear when this deterioration begins and whether physical activity (PA) influences it. We assessed the independent relationships of adverse LVDF in adolescents with different PA intensities, compared to the association with adiposity. The impact of adverse LVDF from low PA on cardiorespiratory fitness was examined. Methods: In 127 adolescents (aged 11‐18 years), we assessed LVDF by echocardiography, 7‐day PA by wrist‐worn accelerometry, adiposity Z scores by bioimpedance, and peak oxygen consumption by cardiopulmonary exercise testing (OxSOCRATES [Oxfordshire Sedentariness, Obesity, and Cardiometabolic Risk in Adolescents: A Trial of Exercise in Schools] study; NCT04118543). Adverse LVDF was defined using a body surface area–adjusted septal early diastolic tissue peak velocity Z score (<−2) based on pediatric reference values. Results: Most participants with overweight (96%) or obesity (90%) had low vigorous PA (VPA). Rates of adverse LVDF were higher in groups with normal weight/low VPA (22%), overweight (28%), and obesity (45%) compared with the normal weight/high VPA group (0%; all P Z score reduced the odds of adverse LVDF (odds ratio [OR], 0.20 [0.10–0.40]), independent ( P =0.016) of the weaker relationship with adiposity Z score (OR, 0.57 [0.40–0.82]). Less intense PA was not associated with LVDF. Causal mediation analysis showed that those who do 5 versus 15 minutes of daily VPA had 2.4 mL/kg per minute lower peak oxygen consumption because of adverse LVDF (indirect effect). Conclusions: Low VPA in adolescence, independent of adiposity, is linked to adverse LVDF. Such impairment predicts worse peak oxygen consumption. VPA appears important for preserving LVDF in the young.
- 18 August 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (16) , e041806
Open AccessEarly Cardiac Dysfunction in Adolescents With Low Vigorous Physical Activity
Background: Adverse left ventricular diastolic function (LVDF) is an early marker of cardiac dysfunction that worsens with age and can lead to heart failure. It is unclear when this deterioration begins and whether physical activity (PA) influences it. We assessed the independent relationships of adverse LVDF in adolescents with different PA intensities, compared to the association with adiposity. The impact of adverse LVDF from low PA on cardiorespiratory fitness was examined. Methods: In 127 adolescents (aged 11‐18 years), we assessed LVDF by echocardiography, 7‐day PA by wrist‐worn accelerometry, adiposity Z scores by bioimpedance, and peak oxygen consumption by cardiopulmonary exercise testing (OxSOCRATES [Oxfordshire Sedentariness, Obesity, and Cardiometabolic Risk in Adolescents: A Trial of Exercise in Schools] study; NCT04118543). Adverse LVDF was defined using a body surface area–adjusted septal early diastolic tissue peak velocity Z score (<−2) based on pediatric reference values. Results: Most participants with overweight (96%) or obesity (90%) had low vigorous PA (VPA). Rates of adverse LVDF were higher in groups with normal weight/low VPA (22%), overweight (28%), and obesity (45%) compared with the normal weight/high VPA group (0%; all P Z score reduced the odds of adverse LVDF (odds ratio [OR], 0.20 [0.10–0.40]), independent ( P =0.016) of the weaker relationship with adiposity Z score (OR, 0.57 [0.40–0.82]). Less intense PA was not associated with LVDF. Causal mediation analysis showed that those who do 5 versus 15 minutes of daily VPA had 2.4 mL/kg per minute lower peak oxygen consumption because of adverse LVDF (indirect effect). Conclusions: Low VPA in adolescence, independent of adiposity, is linked to adverse LVDF. Such impairment predicts worse peak oxygen consumption. VPA appears important for preserving LVDF in the young.
- Open Access
- 1 August 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (15) , e030221
Whole‐Body Magnetic Resonance Imaging Assessment of the Contributions of Adipose and Nonadipose Tissues to Cardiovascular Remodeling in Adolescents
Background: Greater body mass index is associated with cardiovascular remodeling in adolescents. However, body mass index cannot differentiate between adipose and nonadipose tissues. We examined how visceral and subcutaneous adipose tissue are linked with markers of early cardiovascular remodeling, independently from nonadipose tissue. Methods and Results: Whole‐body magnetic resonance imaging was done in 82 adolescents (39 overweight/obese; 36 female; median age, 16.3 [interquartile range, 14.4–18.1] years) to measure body composition and cardiovascular remodeling markers. Left ventricular diastolic function was assessed by echocardiography. Waist, waist:height ratio, and body mass index z scores were calculated. Residualized nonadipose tissue, subcutaneous adipose tissue, and visceral adipose tissue variables, uncorrelated with each other, were constructed using partial regression modeling to allow comparison of their individual contributions in a 3‐compartment body composition model. Cardiovascular variables mostly related to nonadipose rather than adipose tissue. Nonadipose tissue was correlated positively with left ventricular mass ( r =0.81), end‐diastolic volume ( r =0.70), stroke volume ( r =0.64), left ventricular mass:end‐diastolic volume ( r =0.37), and systolic blood pressure ( r =0.35), and negatively with heart rate ( r =−0.33) (all P r =−0.42 to −0.48, P =0.0007–0.02) and higher heart rates ( r =0.34, P =0.007) but linked with better systemic vascular resistance ( r =−0.35, P =0.006). There were no significant relationships with visceral adipose tissue and no associations of any compartment with pulse wave velocity. Conclusions: Simple anthropometry does not reflect independent effects of nonadipose tissue and subcutaneous adipose tissue on the adolescent cardiovascular system. This could result in normal cardiovascular adaptations to growth being misinterpreted as pathological sequelae of excess adiposity in studies reliant on such measures.
- 1 August 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (15) , e030221
Open AccessWhole‐Body Magnetic Resonance Imaging Assessment of the Contributions of Adipose and Nonadipose Tissues to Cardiovascular Remodeling in Adolescents
Background: Greater body mass index is associated with cardiovascular remodeling in adolescents. However, body mass index cannot differentiate between adipose and nonadipose tissues. We examined how visceral and subcutaneous adipose tissue are linked with markers of early cardiovascular remodeling, independently from nonadipose tissue. Methods and Results: Whole‐body magnetic resonance imaging was done in 82 adolescents (39 overweight/obese; 36 female; median age, 16.3 [interquartile range, 14.4–18.1] years) to measure body composition and cardiovascular remodeling markers. Left ventricular diastolic function was assessed by echocardiography. Waist, waist:height ratio, and body mass index z scores were calculated. Residualized nonadipose tissue, subcutaneous adipose tissue, and visceral adipose tissue variables, uncorrelated with each other, were constructed using partial regression modeling to allow comparison of their individual contributions in a 3‐compartment body composition model. Cardiovascular variables mostly related to nonadipose rather than adipose tissue. Nonadipose tissue was correlated positively with left ventricular mass ( r =0.81), end‐diastolic volume ( r =0.70), stroke volume ( r =0.64), left ventricular mass:end‐diastolic volume ( r =0.37), and systolic blood pressure ( r =0.35), and negatively with heart rate ( r =−0.33) (all P r =−0.42 to −0.48, P =0.0007–0.02) and higher heart rates ( r =0.34, P =0.007) but linked with better systemic vascular resistance ( r =−0.35, P =0.006). There were no significant relationships with visceral adipose tissue and no associations of any compartment with pulse wave velocity. Conclusions: Simple anthropometry does not reflect independent effects of nonadipose tissue and subcutaneous adipose tissue on the adolescent cardiovascular system. This could result in normal cardiovascular adaptations to growth being misinterpreted as pathological sequelae of excess adiposity in studies reliant on such measures.
- Open Access
- 18 July 2021
- Published by Wiley in Clinical Obesity
- Vol. 11 (5) , e12476
The effect of overweight/obesity on diastolic function in children and adolescents: A meta‐analysis
Summary: Left ventricular diastolic function (LVDF) is an important marker of early cardiovascular remodelling, which has not been well summarized in young people with overweight/obesity. Weighted, random‐effects regression was used to determine the strength of associations of both body mass index (BMI) and homeostatic model assessment of insulin resistance (HOMA‐IR) with LVDF measures, adjusting for age and sex. Six databases were searched after PROSPERO registration (CRD42020177470) from inception to July 2020 for studies that compared LVDF between overweight/obesity and control groups aged ≤24 years, yielding 70 studies (9983 individuals). Quality and risk of bias were assessed using NHLBI tools, with scores of good, fair, and poor for 6, 48, and 16 studies, respectively. Increased BMI was associated with worse LVDF in all measures except early mitral inflow deceleration time, with septal early diastolic tissue peak velocity to late diastolic tissue peak velocity ratio having the strongest association (n = 13 studies, 1824 individuals; r = −0.69; P < 0.001). Elevated HOMA‐IR was also associated with worse LVDF. Although we could not determine the causality of reduced LVDF in young people, our findings should aid the development of paediatric guidelines for the assessment of LVDF and support further work to address the longitudinal consequences of childhood obesity and IR on LVDF.
- 18 July 2021
- Published by Wiley in Clinical Obesity
- Vol. 11 (5) , e12476
Open AccessThe effect of overweight/obesity on diastolic function in children and adolescents: A meta‐analysis
Summary: Left ventricular diastolic function (LVDF) is an important marker of early cardiovascular remodelling, which has not been well summarized in young people with overweight/obesity. Weighted, random‐effects regression was used to determine the strength of associations of both body mass index (BMI) and homeostatic model assessment of insulin resistance (HOMA‐IR) with LVDF measures, adjusting for age and sex. Six databases were searched after PROSPERO registration (CRD42020177470) from inception to July 2020 for studies that compared LVDF between overweight/obesity and control groups aged ≤24 years, yielding 70 studies (9983 individuals). Quality and risk of bias were assessed using NHLBI tools, with scores of good, fair, and poor for 6, 48, and 16 studies, respectively. Increased BMI was associated with worse LVDF in all measures except early mitral inflow deceleration time, with septal early diastolic tissue peak velocity to late diastolic tissue peak velocity ratio having the strongest association (n = 13 studies, 1824 individuals; r = −0.69; P < 0.001). Elevated HOMA‐IR was also associated with worse LVDF. Although we could not determine the causality of reduced LVDF in young people, our findings should aid the development of paediatric guidelines for the assessment of LVDF and support further work to address the longitudinal consequences of childhood obesity and IR on LVDF.
- Open Access
Associations of Global Country Profiles and Modifiable Risk Factors with COVID-19 Cases and Deaths
Modifiable risk factors affect SARS-CoV-2 infection and mortality raising the possibility that lifestyle modification could play a role. This has not been studied at a global level. We analysed publicly available data from countries reporting COVID-19 cases and deaths. Associations of modifiable risk factors with total cases and excess deaths were determined with and without adjustment for confounders. 4,670,832 cases and 311,384 deaths were reported by 181 countries by 18th May 2020. Wealthier countries had the greatest caseload. Obesity was the primary modifiable risk factor for infection and greater age, male sex, physical inactivity and low salt consumption were associated with excess deaths. Obesity was less influential on mortality than physical inactivity. Globally, obesity confers vulnerability to SARS-CoV-2 infection and physical inactivity likely explains the greater mortality in the obese. High salt consumption may induce reductions in tissue ACE2 expression and subsequently reduce mortality rates.
Open AccessAssociations of Global Country Profiles and Modifiable Risk Factors with COVID-19 Cases and Deaths
Modifiable risk factors affect SARS-CoV-2 infection and mortality raising the possibility that lifestyle modification could play a role. This has not been studied at a global level. We analysed publicly available data from countries reporting COVID-19 cases and deaths. Associations of modifiable risk factors with total cases and excess deaths were determined with and without adjustment for confounders. 4,670,832 cases and 311,384 deaths were reported by 181 countries by 18th May 2020. Wealthier countries had the greatest caseload. Obesity was the primary modifiable risk factor for infection and greater age, male sex, physical inactivity and low salt consumption were associated with excess deaths. Obesity was less influential on mortality than physical inactivity. Globally, obesity confers vulnerability to SARS-CoV-2 infection and physical inactivity likely explains the greater mortality in the obese. High salt consumption may induce reductions in tissue ACE2 expression and subsequently reduce mortality rates.
- Open Access
- 21 November 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (12) , 2036
Tissue Sodium Content and Arterial Hypertension in Obese Adolescents
Early-onset obesity is known to culminate in type 2 diabetes, arterial hypertension and subsequent cardiovascular disease. The role of sodium (Na+) homeostasis in this process is incompletely understood, yet correlations between Na+ accumulation and hypertension have been observed in adults. We aimed to investigate these associations in adolescents. A cohort of 32 adolescents (13–17 years), comprising 20 obese patients, of whom 11 were hypertensive, as well as 12 age-matched controls, underwent 23Na-MRI of the left lower leg with a standard clinical 3T scanner. Median triceps surae muscle Na+ content in hypertensive obese (11.95 mmol/L [interquartile range 11.62–13.66]) was significantly lower than in normotensive obese (13.63 mmol/L [12.97–17.64]; p = 0.043) or controls (15.37 mmol/L [14.12–16.08]; p = 0.012). No significant differences were found between normotensive obese and controls. Skin Na+ content in hypertensive obese (13.33 mmol/L [11.53–14.22] did not differ to normotensive obese (14.12 mmol/L [13.15–15.83]) or controls (11.48 mmol/L [10.48–12.80]), whereas normotensive obese had higher values compared to controls (p = 0.004). Arterial hypertension in obese adolescents is associated with low muscle Na+ content. These findings suggest an early dysregulation of Na+ homeostasis in cardiometabolic disease. Further research is needed to determine whether this association is causal and how it evolves in the transition to adulthood.
- 21 November 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (12) , 2036
Open AccessTissue Sodium Content and Arterial Hypertension in Obese Adolescents
Early-onset obesity is known to culminate in type 2 diabetes, arterial hypertension and subsequent cardiovascular disease. The role of sodium (Na+) homeostasis in this process is incompletely understood, yet correlations between Na+ accumulation and hypertension have been observed in adults. We aimed to investigate these associations in adolescents. A cohort of 32 adolescents (13–17 years), comprising 20 obese patients, of whom 11 were hypertensive, as well as 12 age-matched controls, underwent 23Na-MRI of the left lower leg with a standard clinical 3T scanner. Median triceps surae muscle Na+ content in hypertensive obese (11.95 mmol/L [interquartile range 11.62–13.66]) was significantly lower than in normotensive obese (13.63 mmol/L [12.97–17.64]; p = 0.043) or controls (15.37 mmol/L [14.12–16.08]; p = 0.012). No significant differences were found between normotensive obese and controls. Skin Na+ content in hypertensive obese (13.33 mmol/L [11.53–14.22] did not differ to normotensive obese (14.12 mmol/L [13.15–15.83]) or controls (11.48 mmol/L [10.48–12.80]), whereas normotensive obese had higher values compared to controls (p = 0.004). Arterial hypertension in obese adolescents is associated with low muscle Na+ content. These findings suggest an early dysregulation of Na+ homeostasis in cardiometabolic disease. Further research is needed to determine whether this association is causal and how it evolves in the transition to adulthood.